Navigate FDA 524b to get your medical cyber device to market

This document explains FDA amendment 524b and how it elevates cybersecurity as a core component of medical device safety, detailing device classifications, premarket submission pathways (510(k), PMA, De Novo, HDE), the eSTAR-enabled submission and review process, and the extensive evidence required for regulatory compliance. It stresses starting early and embedding strong cybersecurity hygiene—such as penetration testing, SBOM practices, and post-market vulnerability management—throughout development to streamline approval and reduce risk.